These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11411094)

  • 21. Inclusion body myopathy associated with motor neuron syndrome: three case reports.
    Cafforio G; Pistolesi S; D'Avino C; Galluzzi F; Patricelli A; Solito B; Fontanini G; Siciliano G
    Clin Neuropathol; 2005; 24(1):36-41. PubMed ID: 15696783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot trial of etanercept in the treatment of inclusion-body myositis.
    Barohn RJ; Herbelin L; Kissel JT; King W; McVey AL; Saperstein DS; Mendell JR
    Neurology; 2006 Jan; 66(2 Suppl 1):S123-4. PubMed ID: 16432140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis.
    Cox FM; Reijnierse M; van Rijswijk CS; Wintzen AR; Verschuuren JJ; Badrising UA
    Rheumatology (Oxford); 2011 Jun; 50(6):1153-61. PubMed ID: 21288962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study.
    Krivickas LS; Amato AA; Krishnan G; Murray AV; Frontera WR
    Neuromuscul Disord; 2005 May; 15(5):349-54. PubMed ID: 15833427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inclusion body myositis and neuromuscular diseases with rimmed vacuoles].
    Figarella-Branger D; Pellissier JF; Pouget J; Calore EE; Azulay JP; Desnuelle C; Serratrice G
    Rev Neurol (Paris); 1992; 148(4):281-90. PubMed ID: 1332175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inclusion body myositis associated with chronic thyroiditis, Sjögren's syndrome and autoimmune cholangitis].
    Hama K; Miwa H; Nishino I; Nonaka I; Kondo T
    No To Shinkei; 2004 Jun; 56(6):503-7. PubMed ID: 15328839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased aging in primary muscle cultures of sporadic inclusion-body myositis.
    Morosetti R; Broccolini A; Sancricca C; Gliubizzi C; Gidaro T; Tonali PA; Ricci E; Mirabella M
    Neurobiol Aging; 2010 Jul; 31(7):1205-14. PubMed ID: 18823681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inclusion body myositis: diagnosis, pathogenesis, and treatment options.
    Solorzano GE; Phillips LH
    Rheum Dis Clin North Am; 2011 May; 37(2):173-83, v. PubMed ID: 21444018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sporadic inclusion body myositis: counts of different types of abnormal fibers.
    Pruitt JN; Showalter CJ; Engel AG
    Ann Neurol; 1996 Jan; 39(1):139-43. PubMed ID: 8572661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inclusion body myositis in connective tissue disorders: case report and review of the literature.
    Derk CT; Vivino FB; Kenyon L; Mandel S
    Clin Rheumatol; 2003 Oct; 22(4-5):324-8. PubMed ID: 14576992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance training with vascular occlusion in inclusion body myositis: a case study.
    Gualano B; Neves M; Lima FR; Pinto AL; Laurentino G; Borges C; Baptista L; Artioli GG; Aoki MS; Moriscot A; Lancha AH; Bonfá E; Ugrinowitsch C
    Med Sci Sports Exerc; 2010 Feb; 42(2):250-4. PubMed ID: 19927034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis.
    Dion E; Cherin P; Payan C; Fournet JC; Papo T; Maisonobe T; Auberton E; Chosidow O; Godeau P; Piette JC; Herson S; Grenier P
    J Rheumatol; 2002 Sep; 29(9):1897-906. PubMed ID: 12233884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis.
    Kumamoto T; Ueyama H; Tsumura H; Toyoshima I; Tsuda T
    Acta Neuropathol; 2004 Jan; 107(1):59-65. PubMed ID: 14513262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials.
    Dalakas MC
    Neurol Sci; 2003 Oct; 24 Suppl 4():S256-9. PubMed ID: 14598055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.
    Raju R; Dalakas MC
    Brain; 2005 Aug; 128(Pt 8):1887-96. PubMed ID: 15857930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isokinetic strength testing for evaluating the efficacy of intravenous immune globulin therapy for inclusion body myositis.
    Dasque F; Laroche M; Marque P; Le Vourc'h P; Moulinier L; Maziéres B; Roques CF
    Rev Rhum Engl Ed; 1995 Oct; 62(9):598-601. PubMed ID: 8574634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion-body myositis: clinical, diagnostic, and pathologic aspects.
    Engel WK; Askanas V
    Neurology; 2006 Jan; 66(2 Suppl 1):S20-9. PubMed ID: 16432141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
    Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
    Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis.
    Muscle Study Group
    Neurology; 2004 Aug; 63(4):718-20. PubMed ID: 15326251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.